The Role of Macular Pigment Carotenoids in the Pathogenesis and Treatment of Macular Telangiectasia Type 2 (MacTel)

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
Paul S. Bernstein, University of Utah
ClinicalTrials.gov Identifier:
NCT01354093
First received: May 12, 2011
Last updated: December 11, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)